Ferreira, PG; Jares, P; Rico, D; Gomez-Lopez, G; Martinez-Trillos, A; Villamor, N; Ecker, S; ... Guigo, R; + view all Ferreira, PG; Jares, P; Rico, D; Gomez-Lopez, G; Martinez-Trillos, A; Villamor, N; Ecker, S; Gonzalez-Perez, A; Knowles, DG; Monlong, J; Johnson, R; Quesada, V; Djebali, S; Papasaikas, P; Lopez-Guerra, M; Colomer, D; Royo, C; Cazorla, M; Pinyol, M; Clot, G; Aymerich, M; Rozman, M; Kulis, M; Tamborero, D; Gouin, A; Blanc, J; Gut, M; Gut, I; Puente, XS; Pisano, DG; Martin-Subero, JI; Lopez-Bigas, N; Lopez-Guillermo, A; Valencia, A; Lopez-Otin, C; Campo, E; Guigo, R; - view fewer (2014) Transcriptome characterization by RNA sequencing identifies a major molecular and clinical subdivision in chronic lymphocytic leukemia. Genome Research , 24 (2) pp. 212-226. 10.1101/gr.152132.112.

Preview	Text (Published article) Ferreira et al. - 2014 - Transcriptome characterization by RNA sequencing identifies a major molecular and clinical subdivision in chron.pdf - Published Version Download (1MB) | Preview
Preview	Text (Supplementary information) Ferreira_Transcriptome_characterization_by_RNA_sequencing_Supplementary.pdf Download (11MB) | Preview
	Spreadsheet (Supplementary spreadsheet 1) Ferreira_Transcriptome_characterization_by_RNA_sequencing_S1.xls Download (40kB)
	Spreadsheet (Supplementary spreadsheet 2) Ferreira_Transcriptome_characterization_by_RNA_sequencing_S2.xls Download (1MB)
	Spreadsheet (Supplementary spreadsheet 3) Ferreira_Transcriptome_characterization_by_RNA_sequencing_S3.xls Download (1MB)
	Spreadsheet (Supplementary spreadsheet 4) Ferreira_Transcriptome_characterization_by_RNA_sequencing_S4.xls Download (52kB)
	Spreadsheet (Supplementary spreadsheet 5) Ferreira_Transcriptome_characterization_by_RNA_sequencing_S5.xlsx Download (1MB)

Abstract

Chronic lymphocytic leukemia (CLL) has heterogeneous clinical and biological behavior. Whole-genome and -exome sequencing has contributed to the characterization of the mutational spectrum of the disease, but the underlying transcriptional profile is still poorly understood. We have performed deep RNA sequencing in different subpopulations of normal B-lymphocytes and CLL cells from a cohort of 98 patients, and characterized the CLL transcriptional landscape with unprecedented resolution. We detected thousands of transcriptional elements differentially expressed between the CLL and normal B cells, including protein-coding genes, noncoding RNAs, and pseudogenes. Transposable elements are globally derepressed in CLL cells. In addition, two thousand genes—most of which are not differentially expressed—exhibit CLL-specific splicing patterns. Genes involved in metabolic pathways showed higher expression in CLL, while genes related to spliceosome, proteasome, and ribosome were among the most down-regulated in CLL. Clustering of the CLL samples according to RNA-seq derived gene expression levels unveiled two robust molecular subgroups, C1 and C2. C1/C2 subgroups and the mutational status of the immunoglobulin heavy variable (IGHV) region were the only independent variables in predicting time to treatment in a multivariate analysis with main clinico-biological features. This subdivision was validated in an independent cohort of patients monitored through DNA microarrays. Further analysis shows that B-cell receptor (BCR) activation in the microenvironment of the lymph node may be at the origin of the C1/C2 differences.

Download activity - last month

Export as XMLJSONCSV

Download activity - last 12 months

Export as CSVJSONXML

Downloads by country - last 12 months

Export as CSVXMLJSON

Archive Staff Only

View Item